Richard Scalzo
Former Senior Vice President, Head of Finance and AdministrationatDyne Therapeutics· In proxies 2024–2025
Pay in FY2024Dyne Therapeutics stock +77.1% the same year
Richard Scalzo was paid $2.5M in FY2024 (Dec). Dyne Therapeutics stock rose 77.1% that year.
Pay$100 in the stock at the end of FY23 → $177
Experience
- Dyne TherapeuticsPublic company · 2 yr
- Former Senior Vice President, Head of Finance and Administration2024 – Present · 2 yrStock in role +34%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?